Women's Health

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with Karen Kier, PhD, RPh, BCPS, BCACP, to discuss warning labels for hormonal replacement therapy.

The FDA expands Addyi's approval, offering hope for women under 65 with low sexual desire, marking a significant advancement in women's sexual health.

Amid a lack of research on their specific perspectives, women with epilepsy share their experiences with pregnancy and reproductive health.

In an exploration of key stakeholders’ perspectives, researchers assess a lifestyle intervention for cardiometabolic health among women during or after pregnancy.

Researchers want to bolster evidence regarding the known link between maternal mental health and childhood nutritional status.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with pharmacists from Ohio State University to discuss smoking trends among women.

Researchers explore the no-cost uptake of 2 separate emergency contraception methods.

Researchers address the potential association of access to maternal care with the increased risk of infant mortality.

Due to the lived realities and trajectory of risk throughout their lifetime, researchers believe women require novel approaches in their cardiovascular health care needs.

A secondary analysis of the obesity-fertility lifestyle intervention program explored how it impacted the behavior of women with obesity and subfertility.

Researchers investigate women’s experiences in accessing either prescription or OTC contraceptives.

Due to humans’ physiologically premature nature, researchers explore maternal psychological distress and childhood neurodevelopment.

Conversations about contraceptive options have grown more frequent—and often more polarized—on social media platforms.

Through interviews with pregnant and new mothers, researchers explore patient perspectives regarding interactions with providers on cannabis use during pregnancy.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Marie Barnard, PhD, about the ways in which pharmacists can support patients experiencing intimate partner violence.

Further, they found weight loss prior to 75-g oral glucose tolerance test was a preventive factor for both impaired glucose tolerance and diabetes.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Hannah Fish, PharmD, CPHQ, about the NCPA’s maternal immunizations tool kit and pharmacist support for mothers.

Prior to the government shutdown, the FDA approved a generic version of mifeprisone without a public announcement.

As contraceptive care services remain fragmented across many US states, pharmacists are seemingly rising as key touch points for women’s health management and various types of reproductive care.

In part 2 of our interview, Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss the evolution of contraceptive services and how pharmacy is supporting rural communities and their patients.

In the final part of our interview with Mark Garofoli, PharmD, BCGP, CPE, CTTS, he discusses what the future will hold regarding clinical decision-making following the reported acetaminophen-autism link.

Pharmacists are on the front line for patients looking to self-manage their menstrual pain, making their role invaluable in women’s health.

Amid the prominent use of vaping in today’s society, researchers assess how it impacts pregnancy outcomes, including preterm birth, low birth weight, and small for gestational age.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, also known as “the Pain Guy,” discusses his initial reactions upon learning about the Trump Administration linking acetaminophen use with autism.

Pharmacists enhance menstrual pain management by integrating holistic strategies, empowering women with personalized care and evidence-based guidance for better health outcomes.